PALATIN TECHNOLOGIES, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PALATIN TECHNOLOGIES, INC. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $4.46M.
- PALATIN TECHNOLOGIES, INC. stock issued during period, value, new issues for the quarter ending 2020-03-31 was $0.00.
- PALATIN TECHNOLOGIES, INC. stock issued during period, value, new issues for the quarter ending 2019-12-31 was $1.00M, a 3199.52% increase year-over-year.
- PALATIN TECHNOLOGIES, INC. stock issued during period, value, new issues for the quarter ending 2019-09-30 was $579.73K, a 73.91% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. stock issued during period, value, new issues for fiscal 2012 was $21.03M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-03-31 | $4.46M 10-Q · filed 2026-05-13 | |
| 2020-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-14 | |
| 2019-12-31 | $1.00M 10-Q · filed 2021-02-16 | |
| 2019-09-30 | $579.73K 10-Q · filed 2020-11-16 | |
| 2019-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | |
| 2018-12-31 | $30.36K 10-Q · filed 2020-02-10 | |
| 2018-09-30 | $2.22M 10-Q · filed 2019-11-12 | |
| 2012-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-13 | |
| 2012-09-30 | $21.03M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $21.03M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |